Boufraqech M - Search Results

1

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.

Zhang L, Zhang Y, Mehta A, Boufraqech M, Davis S, Wang J, Tian Z, Yu Z, Boxer MB, Kiefer JA, Copland JA, Smallridge RC, Li Z, Shen M, Kebebew E. Zhang L, et al. Among authors: boufraqech m. Oncotarget. 2015 Apr 20;6(11):9073-85. doi: 10.18632/oncotarget.3268. Oncotarget. 2015. PMID: 25940539 Free PMC article.

2

miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Boufraqech M, Nilubol N, Zhang L, Gara SK, Sadowski SM, Mehta A, He M, Davis S, Dreiling J, Copland JA, Smallridge RC, Quezado MM, Kebebew E. Boufraqech M, et al. Cancer Res. 2015 Jan 15;75(2):367-77. doi: 10.1158/0008-5472.CAN-14-2304. Epub 2014 Dec 8. Cancer Res. 2015. PMID: 25488748 Free PMC article.

3

Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.

Mehta A, Zhang L, Boufraqech M, Liu-Chittenden Y, Zhang Y, Patel D, Davis S, Rosenberg A, Ylaya K, Aufforth R, Li Z, Shen M, Kebebew E. Mehta A, et al. Among authors: boufraqech m. Clin Cancer Res. 2015 Sep 15;21(18):4123-32. doi: 10.1158/1078-0432.CCR-14-3251. Epub 2015 May 5. Clin Cancer Res. 2015. PMID: 25944801 Free PMC article.

4

Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.

Sadowski SM, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, Li Z, Shen M, Kebebew E. Sadowski SM, et al. Among authors: boufraqech m. Oncotarget. 2015 Jul 20;6(20):18038-49. doi: 10.18632/oncotarget.3833. Oncotarget. 2015. PMID: 25945839 Free PMC article.

5

Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.

Mehta A, Zhang L, Boufraqech M, Zhang Y, Patel D, Shen M, Kebebew E. Mehta A, et al. Among authors: boufraqech m. Endocr Relat Cancer. 2015 Jun;22(3):319-29. doi: 10.1530/ERC-14-0510. Endocr Relat Cancer. 2015. PMID: 25972243

6

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.

Zhang L, Boufraqech M, Lake R, Kebebew E. Zhang L, et al. Among authors: boufraqech m. Oncotarget. 2016 Mar 29;7(13):16517-28. doi: 10.18632/oncotarget.7760. Oncotarget. 2016. PMID: 26934320 Free PMC article.

7

LOX is a novel mitotic spindle-associated protein essential for mitosis.

Boufraqech M, Wei D, Weyemi U, Zhang L, Quezado M, Kalab P, Kebebew E. Boufraqech M, et al. Oncotarget. 2016 May 17;7(20):29023-35. doi: 10.18632/oncotarget.8628. Oncotarget. 2016. PMID: 27296552 Free PMC article.

8

Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.

Kotian S, Zhang L, Boufraqech M, Gaskins K, Gara SK, Quezado M, Nilubol N, Kebebew E. Kotian S, et al. Among authors: boufraqech m. Clin Cancer Res. 2017 Sep 1;23(17):5044-5054. doi: 10.1158/1078-0432.CCR-17-1043. Epub 2017 Jun 9. Clin Cancer Res. 2017. PMID: 28600475 Free PMC article.

9

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.

Nilubol N, Boufraqech M, Zhang L, Gaskins K, Shen M, Zhang YQ, Gara SK, Austin CP, Kebebew E. Nilubol N, et al. Among authors: boufraqech m. Oncotarget. 2018 Aug 31;9(68):33030-33042. doi: 10.18632/oncotarget.26050. eCollection 2018 Aug 31. Oncotarget. 2018. PMID: 30250647 Free PMC article.

10

Diagnosis of thyroid cancer: state of art.

Boufraqech M, Patel D, Xiong Y, Kebebew E. Boufraqech M, et al. Expert Opin Med Diagn. 2013 Jul;7(4):331-42. doi: 10.1517/17530059.2013.800481. Epub 2013 May 23. Expert Opin Med Diagn. 2013. PMID: 23701167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page